1. Home
  2. CVE Database
  3. CVE-2022-48224
HIGH · 7.3

CVE-2022-48224

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write access within Program Files). Standard users can replace files within this direc...

Vulnerability Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write access within Program Files). Standard users can replace files within this directory that get executed with elevated privileges, leading to a complete arbitrary code execution (elevation of privileges).

CVSS Score

7.3

HIGH

CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H
Attack Vector
LOCAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
GbgplcAcuant Acufill Sdk< 10.22.02.03

Related Weaknesses (CWE)

CWE-427

References

FAQ

What is CVE-2022-48224?

CVE-2022-48224 is a vulnerability with a CVSS score of 7.3 (HIGH). An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write access within Program Files). Standard users can replace files within this direc...

How severe is CVE-2022-48224?

CVE-2022-48224 has been rated HIGH with a CVSS base score of 7.3/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-48224?

Check the references section above for vendor advisories and patch information. Affected products include: Gbgplc Acuant Acufill Sdk.